methotrexate has been researched along with Alpha Virus Infections in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, W; Herrero, LJ; Mahalingam, S; Rulli, NE; Sheng, KC; Taylor, A | 1 |
Anuradha, V; Chopra, A; Kunjir, V; Lagoo-Joshi, V; Saluja, M; Salvi, S | 1 |
Seetharam, KA; Sridevi, K | 1 |
Ganu, AS; Ganu, MA | 1 |
4 other study(ies) available for methotrexate and Alpha Virus Infections
Article | Year |
---|---|
Methotrexate treatment causes early onset of disease in a mouse model of Ross River virus-induced inflammatory disease through increased monocyte production.
Topics: Alphavirus Infections; Animals; Antirheumatic Agents; Arthritis; CD11b Antigen; Disease Models, Animal; Inflammation; Inflammation Mediators; Methotrexate; Mice; Monocytes; Muscle, Skeletal; Ross River virus | 2013 |
Chikungunya virus aches and pains: an emerging challenge.
Topics: Alphavirus Infections; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Chikungunya virus; Chronic Disease; Humans; Hydroxychloroquine; Methotrexate; Musculoskeletal Diseases; Sulfasalazine | 2008 |
Chikungunya infection: a new trigger for psoriasis.
Topics: Adolescent; Adult; Alphavirus Infections; Chikungunya Fever; Child; Female; Humans; Male; Methotrexate; Middle Aged; Psoriasis; Ultraviolet Therapy; Young Adult | 2011 |
Post-chikungunya chronic arthritis--our experience with DMARDs over two year follow up.
Topics: Adult; Aged; Alphavirus Infections; Antirheumatic Agents; Arthritis, Rheumatoid; Chikungunya Fever; Chikungunya virus; Chronic Disease; Drug Therapy, Combination; Epidemics; Female; Follow-Up Studies; Humans; Hydroxychloroquine; Male; Methotrexate; Middle Aged; Severity of Illness Index; Sulfasalazine; Treatment Outcome; Young Adult | 2011 |